Négociation Fresenius SE & Co KGaA - FRE CFD

Fresenius is a world leading provider of innovative products and services for dialysis, hospital and outpatient treatment. The company was founded in 1912, first as a pharmaceutical lab, then a small-town manufacturer. Today, Fresenius operates in more than 100 countries. The Fresenius Group is comprised of four independent business segments: Fresenius Medical Care, a dialysis care company; Fresenius Helios, a private hospital operator; Fresenius Kabi, a drug and clinical nutrition supplier; Fresenius Vamed, a healthcare facilities developer. Fresenius share price info: Fresenius shares are traded on the stock exchanges in Frankfurt, Munich and Dusseldorf. Regarding market cap, the group belongs to Germany’s 30 major companies. As a top-rated blue chip company, Fresenius is a constituent of the Germany’s DAX index and Europe's EURO STOXX 50. FRE stock is featured in the following indices: STOXX Europe 600 Health Care, the FTSEurofirst 300, the DAXsector Pharma & Healthcare.